Theorem (now Fortrea)
Company intelligence

Theorem (now Fortrea) Company Intelligence, Employees & Contact Signals

Contact coverage
Email + phone
Visible profile or company source data includes email and phone channels. 2 visible profiles include direct contact evidence.
People graph depth
2 signals
2 mapped workforce signals against a 273 employee size estimate.
Account research
5 steps
Account research checklist combines person-level contact coverage, ICP fit, related-company graph, domain trust, and people graph depth; raw contact values are hidden.
Affiliate graph
1 page
1 affiliated page found in the source record.
Evidence quality 100/100 Priority intelligence record

AeroLeads company intelligence

Theorem (now Fortrea) workforce and contactability signals

Evidence from AeroLeads company records, matched professional profiles, and related company graph.

High confidence
Intelligence completeness
Basic intelligence record
4 of 11 major intelligence groups are available for this company.
Profile graph
Sample profile graph
2 mapped workforce signals against a 273 employee size estimate.
Visible contact sample
2
Displayed people with email or phone data.
Social followers
22.46K
Audience size from company social data.
Affiliated pages
1
Related brands or company pages in the source record.

Data methodology

AeroLeads renders only source-backed fields for this company page.

5 source groups
Company record Matched profile graph Email-pattern aggregate Related company graph Company signal fields
Blank source fields are omitted
Related companies are ordered deterministically
Structured data uses aggregate counts only

Intelligence completeness

4 of 11 major intelligence groups are available for this company.

4 / 11 groups
Basic intelligence record 36.4%
Contactability Email intelligence Domain confidence Market and peer context

Evidence quality

This page clears the 60+ AeroLeads company-intelligence evidence threshold.

100 / 100
Priority intelligence record Threshold 60+
Employee email coverage Employee phone coverage Email usability mix Related company graph Peer graph strength Peer position benchmark
Contactability
7 signals
Employee email coverage, Employee phone coverage, Email usability mix
Market and peer context
15 signals
Related company graph, Peer graph strength, Peer position benchmark
Workforce graph
7 signals
Workforce location footprint, Contactable workforce location alignment, Profile graph coverage
Company momentum
3 signals
Company signal breadth, Company momentum score, Company ownership signal
Source trust
7 signals
Domain confidence, Intelligence completeness, Company description
Decision-maker intelligence
1 signal
Account research checklist
34 additional source-backed evidence signals are counted in this page quality score.

Prospecting readiness

Theorem (now Fortrea) shows research-first prospecting fit based on person-level contact coverage, people graph depth, and peer context.

35 / 100
Research-first prospecting fit Corroborated prospecting evidence

Prospecting evidence combines person-level contact coverage, people graph depth, and peer context; raw contact values are hidden.

ICP fit
Research ICP fit

ICP fit combines company size, market specificity, and contactability; raw contact values are hidden.

50 / 100
Company size
273 employees
Employee estimate is in a common outbound prospecting range.
Market specificity
Focused market profile
15 market classification signals across categories, specialties, and related peer industries.
Reachability
High-confidence contact evidence
2 current or verified professional email signals, and multi-channel contact coverage; raw addresses and numbers are hidden.
Account research checklist
Source-backed account research checklist

Account research checklist combines person-level contact coverage, ICP fit, related-company graph, domain trust, and people graph depth; raw contact values are hidden.

5 steps
Confirm contact coverage
High-confidence contact evidence
2 current or verified professional email signals, and multi-channel contact coverage; raw addresses and numbers are hidden.
Validate ICP fit
Research ICP fit
ICP fit combines company size, market specificity, and contactability; raw contact values are hidden.
Compare related peers
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
Check domain trust
Mixed domain alignment
Domain evidence combines website domain and social profile; raw email addresses are hidden.
Review people graph depth
Sample profile graph
2 mapped workforce signals against a 273 employee size estimate.
Contact coverage
High-confidence contact evidence
2 current or verified professional email signals, and multi-channel contact coverage; raw addresses and numbers are hidden.
People graph depth
Sample profile graph
2 mapped workforce signals against a 273 employee size estimate.
Peer context
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Decision-maker evidence missing: No mapped decision-maker cluster is strong enough to summarize.

Domain trust signals

Domain confidence for fortrea.com is based on website domain and social profile.

35 / 100
Mixed domain alignment Limited domain evidence

Domain evidence combines website domain and social profile; raw email addresses are hidden.

Website domain
fortrea.com
The official website domain is available from the company source record.
Social profile
LinkedIn organization page
A LinkedIn organization page is present for this company record.
Employee email mismatch: Visible employee email signals do not match the official domain.

AeroLeads coverage snapshot

Profile sample
2
Visible people attached to this company page.
Profile graph depth
Sample profile graph
2 mapped workforce signals against a 273 employee size estimate.
Contactable sample
2
Visible people with email or phone data.
Contact channel mix
Multi-channel contact coverage
Visible profile or company source data includes email and phone channels.
Contact evidence confidence
High-confidence contact evidence
2 current or verified professional email signals, and multi-channel contact coverage; raw addresses and numbers are hidden.
Email domain confidence
Non-official email coverage
Visible email signals use non-official domains only.
Domain confidence
Mixed domain alignment
Domain confidence for fortrea.com is based on website domain and social profile.
Email usability mix
Current email coverage sample
AeroLeads source data includes 7 unique visible email signals; 2 are marked current or verified and 4 are professional-type. Raw addresses are hidden.
Contact data safety
Limited privacy-safe contact intelligence
AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
Company signal breadth
Multi-signal company record
Company-level signals include social audience, ownership, and affiliated pages.
Company momentum score
Limited company momentum score
Momentum score blends contactability and peer position from AeroLeads company and profile evidence.
Company ownership signal
Public company record
Company source record includes source type Public Company, and ticker FTRE.
Audience density
Moderate audience density
22.46K followers against 273 employee estimate, about 82.30 followers per estimated employee.
Specialty signals
10
Specialty tags in the company record.
Market specificity
Focused market profile
15 market classification signals across categories, specialties, and related peer industries.
Peer industry clusters
4
Industries represented by related company records.
Related companies
10
Company graph links available for comparison.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 10 related companies, 4 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Peer benchmark confidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Peer position benchmark
Employee-scale peer position benchmark
Peer-position benchmark shows employee scale above 0% of 9 comparable related peers.
Peer comparison matrix
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
Workforce locations
2
Locations represented in visible profile signals.
Workforce distribution
Multi-location workforce
Visible profile location signals span 2 locations, led by Marcus Hook, Pennsylvania, United States.
Workforce location footprint
Two-city workforce footprint
Visible profile locations span 2 cities across 1 country, led by Marcus Hook.
Workforce geography evidence confidence
Corroborated workforce geography evidence
Workforce geography spans 2 locations across 2 visible profile signals, with reachable evidence across 2 locations. Top workforce hub differs from company location.
Contactable workforce locations
2
Workforce locations represented by visible contact samples.
Top contactable workforce location
Marcus Hook, Pennsylvania, United States
Visible contact samples span 2 workforce locations, led by Marcus Hook, Pennsylvania, United States.
Prospecting fit
Research-first prospecting fit
Theorem (now Fortrea) shows research-first prospecting fit based on person-level contact coverage, people graph depth, and peer context.
ICP fit
Research ICP fit
Theorem (now Fortrea) matches the research ICP fit band for common outbound filters based on company size, market specificity, and contactability.
Account research checklist
Source-backed account research checklist
Account research checklist combines person-level contact coverage, ICP fit, related-company graph, domain trust, and people graph depth; raw contact values are hidden.
Intelligence signal groups
10
AeroLeads signal groups available for this company.

Market focus signals

Primary industry
Hospitals and Health Care
Market specificity
Focused market profile
15 market classification signals across categories, specialties, and related peer industries.
Market evidence tier
High-confidence market evidence
Market evidence combines 15 classification signals from categories, specialties, related peer industries, and description keywords. 6 description-backed keyword signals are included.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 10 related companies, 4 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Top peer industry
Hospitals and Health Care
40% of 10 related peer industry signals.
Peer benchmark evidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Size position
Smaller than most related peers
9 of 9 related employee-estimated peers are higher.
Peer graph strength
Benchmark-ready peer graph
Related peer graph has industry context, employee benchmarks, website records, and social profiles across 10 related companies.
Benchmark dimensions: peer graph strength, size benchmark, and size position.
Categories
Hospitals and Health Care
Specialties
Clinical Trials Biopharma Clinical Analytics Medical Device and Diagnostics Source (FSP/Resourcing) Oncology Ophthalmology Respiratory
Product-market keyword evidence
Description-backed market keywords
Keyword evidence comes from 3 source field groups: Category, Specialty, Description.
Product-market keyword evidence tier: High-confidence product-market keyword evidence. Product-market keyword evidence combines 17 unique market keywords, 3 source field groups, and 6 description-backed keywords (1 category, 10 specialty, and 6 description).
Hospitals and Health Care · Category Clinical Trials · Specialty Biopharma · Specialty Clinical Analytics · Specialty Medical Device and Diagnostics · Specialty Source (FSP/Resourcing) · Specialty Oncology · Specialty Ophthalmology · Specialty Respiratory · Specialty Anti-infectives/Vaccines · Specialty Dermatology · Specialty keep updated · Description
Related peer industries
Peer-industry evidence tier: High-confidence peer-industry evidence. Peer-industry evidence combines 10 related companies, 4 peer-industry clusters, and top peer industry Hospitals and Health Care at 40.0%.
Hospitals and Health Care 4 peers
40.0% of related peer industries
Biotechnology Research 3 peers
30.0% of related peer industries
Research Services 2 peers
20.0% of related peer industries
Pharmaceutical Manufacturing 1 peer
10.0% of related peer industries

Company signals

Company signal breadth
Multi-signal company record
Company-level signals include social audience, ownership, and affiliated pages.
Corroborated company record evidence: Company record evidence combines 3 source-backed company signal types: social audience, ownership, and affiliated pages.
Social audience
22.46K
Followers in the company source record.
Social audience evidence tier: Measured social-audience evidence. Social audience evidence uses 22.46K followers from source field social_followers.
Audience density
Moderate audience density
22.46K followers against 273 employee estimate, about 82.30 followers per estimated employee.
Audience-density evidence tier: High-confidence audience-density evidence. Audience-density evidence combines 22.46K social followers, 273 employee estimate, and 82.30 followers per estimated employee.
Company ownership
Public company record
Company source record includes source type Public Company, and ticker FTRE.
Company ownership evidence tier: Ticker ownership evidence. Ownership evidence combines source type Public Company and ticker FTRE from structured company source fields.
Ticker: FTRE
Affiliated pages
1
Affiliate evidence tier: Limited affiliate evidence. Affiliate evidence combines 1 affiliated page and 1 distinct industry from structured affiliated-page source records.
Chiltern · Hospitals and Health Care

Workforce geography

Aggregated from 2 visible profile location signals.

Workforce geography evidence
Corroborated workforce geography evidence
Workforce geography spans 2 locations across 2 visible profile signals, with reachable evidence across 2 locations. Top workforce hub differs from company location.
Distribution signal
Multi-location workforce
Visible profile location signals span 2 locations, led by Marcus Hook, Pennsylvania, United States.
Workforce location footprint
Two-city workforce footprint
Visible profile locations span 2 cities across 1 country, led by Marcus Hook.
Cities
2
Countries
1
Company-location alignment
Top workforce hub differs from company location
The largest visible workforce location is Marcus Hook, Pennsylvania, United States, while the company location is Slough, United Kingdom.
Top workforce hub share: 50.0%
Company-location evidence tier: Workforce-location divergence evidence. Company-location alignment evidence combines company location Slough, United Kingdom, top workforce hub Marcus Hook, Pennsylvania, United States, 50.0% top workforce hub share, and location difference.
Contactable location spread
Multi-location contact coverage
Visible contact samples span 2 workforce locations, led by Marcus Hook, Pennsylvania, United States.
Contactable location evidence tier: Multi-location contactable evidence. Contactable location evidence combines 2 contactable profile location signals, 2 workforce locations, top contactable hub Marcus Hook, Pennsylvania, United States at 50.0%, and company-location alignment.
Contactable workforce hub differs from company location: The largest contactable workforce location is Marcus Hook, Pennsylvania, United States, while the company location is Slough, United Kingdom. Top contactable hub share: 50.0%.
Marcus Hook, Pennsylvania, United States 1 contact
50.0% of contactable location signals
Greater Philadelphia, United States 1 contact
50.0% of contactable location signals
Marcus Hook, Pennsylvania, United States 1 profile
50.0% of visible location signals
Greater Philadelphia, United States 1 profile
50.0% of visible location signals

Contactability signals

Contactability score 100.0%
2 of 2 visible profiles include email or phone signals.
Contact channel mix
Multi-channel contact coverage
Visible profile or company source data includes email and phone channels.
Contact evidence tier
High-confidence contact evidence
2 current or verified professional email signals, and multi-channel contact coverage; raw addresses and numbers are hidden.
Contact data safety
Limited privacy-safe contact intelligence
AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
Aggregate signals
2
Channel coverage
Email and phone aggregate coverage
Evidence groups
2
Limited contact-safety evidence: Contact-safety evidence combines visible profile contact sample and current email metadata; public schema uses aggregate variables only.
Aggregate-only contact schema: Dataset variables use counts, rates, channel labels, freshness bands, and domain-alignment metrics instead of raw contact values.
Email usability mix
Current email coverage sample
AeroLeads source data includes 7 unique visible email signals; 2 are marked current or verified and 4 are professional-type. Raw addresses are hidden.
Email usability evidence tier: Corroborated email usability evidence. Email usability evidence combines 7 unique email signals, 2 current or verified, 4 professional-type, and 28.6% current signal rate; raw addresses are hidden.
2 current or verified 4 professional-type 28.6% current signal rate
Visible people
2
With contact data
2
Email coverage
2
100.0% of visible profiles
Phone coverage
1
50.0% of visible profiles

Email domain intelligence

0 of 7 visible email signals match fortrea.com.

Non-official email coverage: Visible email signals use non-official domains only.
Email identity evidence tier: Non-official email identity evidence. Email identity evidence combines 7 visible email signals, 6 other-domain signals, and 1 personal-domain signal.
0.0% domain match 0 people with official-domain email 7 non-official email signals

Explore related pages

Related company intelligence:

We are now Fortrea. To keep updated on the latest news from Fortrea, please visit our LinkedIn page at https://www.linkedin.com/company/fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.

Company source details

Employees
273
Address
Slough, United Kingdom
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
Website
www.fortrea.com
Keywords
Clinical Trials, Biopharma, Clinical Analytics, Medical Device and Diagnostics, Source (FSP/Resourcing), Oncology, Ophthalmology, Respiratory, Anti-infectives/Vaccines, Dermatology, Data Management, eClinical, Biostatistics, SAS Programming, Clinical Monitoring.
HQ
Slough, Berkshire SL1 4AA
Related companies
IQVIA, Labcorp, ICON plc, PPD, Syneos Health, Parexel, Fortrea, Covance, Sciformix (now Fortrea), Chiltern.
Explore visible people signals for Theorem (now Fortrea) by role, title, or keyword.

2 of 2 visible profiles include email or phone signals in AeroLeads.

Theorem (now Fortrea) Questions

News

Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt - GlobeNewswire

Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt GlobeNewswire

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call - Sahm

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call Sahm

$75.74M Tender Offer: Fortrea to Purchase 7.5% Senior Secured Notes Due 2030; Expires Nov 18, 2025 - Stock Titan

$75.74M Tender Offer: Fortrea to Purchase 7.5% Senior Secured Notes Due 2030; Expires Nov 18, 2025 Stock Titan

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations - Yahoo Finance

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations Yahoo Finance

Fortrea Adopts Limited-Duration Stockholder Rights Plan - Yahoo Finance

Fortrea Adopts Limited-Duration Stockholder Rights Plan Yahoo Finance

30-Year Pharma Industry Leader William Sharbaugh Joins Fortrea Board to Drive Global Drug Development - Stock Titan

30-Year Pharma Industry Leader William Sharbaugh Joins Fortrea Board to Drive Global Drug Development Stock Titan

Fortrea Announces CEO Stepping Down - Yahoo Finance

Fortrea Announces CEO Stepping Down Yahoo Finance

75,000 Restricted Stock Units: Fortrea Awards Major Equity Package to Strategic New Hire - Stock Titan

75,000 Restricted Stock Units: Fortrea Awards Major Equity Package to Strategic New Hire Stock Titan

Fortrea Unlocks FDA-Approved Rifampin Testing for Drug Interaction Studies Through Emery Pharma Alliance - Stock Titan

Fortrea Unlocks FDA-Approved Rifampin Testing for Drug Interaction Studies Through Emery Pharma Alliance Stock Titan

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire

Fortrea Appoints William Sharbaugh to Board of Directors - GlobeNewswire

Fortrea Appoints William Sharbaugh to Board of Directors GlobeNewswire

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire

Fortrea Names Anshul Thakral Chief Executive Officer - GlobeNewswire

Fortrea Names Anshul Thakral Chief Executive Officer GlobeNewswire

Fortrea Reports Second Quarter 2025 Results - GlobeNewswire

Fortrea Reports Second Quarter 2025 Results GlobeNewswire

Fortrea & Emery Pharma Announce Strategic Collaboration to - GlobeNewswire

Fortrea & Emery Pharma Announce Strategic Collaboration to GlobeNewswire

Fortrea Reports First Quarter 2025 Results - GlobeNewswire

Fortrea Reports First Quarter 2025 Results GlobeNewswire

Fortrea Leadership Team Set for Major Presentation at Jefferies Global Healthcare Conference 2025 - Stock Titan

Fortrea Leadership Team Set for Major Presentation at Jefferies Global Healthcare Conference 2025 Stock Titan

Fortrea, Leading CRO Giant, Sets Q2 2025 Earnings Release for August 6 - Key Details Inside - Stock Titan

Fortrea, Leading CRO Giant, Sets Q2 2025 Earnings Release for August 6 - Key Details Inside Stock Titan

Fortrea Awards Massive 2.5M Share Package to New CEO Anshul Thakral: Full Details - Stock Titan

Fortrea Awards Massive 2.5M Share Package to New CEO Anshul Thakral: Full Details Stock Titan

Fortrea Activates Poison Pill Strategy After Third-Party Interest Sparks Takeover Concerns - Stock Titan

Fortrea Activates Poison Pill Strategy After Third-Party Interest Sparks Takeover Concerns Stock Titan

Fortrea Announces CEO Stepping Down - Stock Titan

Fortrea Announces CEO Stepping Down Stock Titan

Fortrea to Add Erin L. Russell to Board of Directors - GlobeNewswire

Fortrea to Add Erin L. Russell to Board of Directors GlobeNewswire

Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance - GlobeNewswire

Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance GlobeNewswire

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials - Yahoo Finance

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials Yahoo Finance

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners - Yahoo Finance

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners Yahoo Finance

FORTREA SELECTS COGNIZANT AS ITS TECHNOLOGY TRANSFORMATION PROVIDER - PR Newswire

FORTREA SELECTS COGNIZANT AS ITS TECHNOLOGY TRANSFORMATION PROVIDER PR Newswire

Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster - Yahoo Finance

Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster Yahoo Finance

Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea - Business Wire

Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea Business Wire

Fortrea Grows Its Non-Commercial Specialty Pharma Offering - Pharmaceutical Commerce

Fortrea Grows Its Non-Commercial Specialty Pharma Offering Pharmaceutical Commerce

Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research - Koreabizwire

Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research Koreabizwire

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery - Koreabizwire

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery Koreabizwire

Fortrea Releases Inaugural Corporate Social Responsibility Report - Koreabizwire

Fortrea Releases Inaugural Corporate Social Responsibility Report Koreabizwire

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K. - Koreabizwire

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K. Koreabizwire

Theorem (now Fortrea) people graph sample